Drugs are getting more effective - including placebos

Onionsoilder

Reaver
Joined
Mar 19, 2007
Messages
3,173
http://www.wired.com/medtech/drugs/magazine/17-09/ff_placebo_effect

It's not only trials of new drugs that are crossing the futility boundary. Some products that have been on the market for decades, like Prozac, are faltering in more recent follow-up tests. In many cases, these are the compounds that, in the late '90s, made Big Pharma more profitable than Big Oil. But if these same drugs were vetted now, the FDA might not approve some of them. Two comprehensive analyses of antidepressant trials have uncovered a dramatic increase in placebo response since the 1980s. One estimated that the so-called effect size (a measure of statistical significance) in placebo groups had nearly doubled over that time.

[...]

Assumption number one was that if a trial were managed correctly, a medication would perform as well or badly in a Phoenix hospital as in a Bangalore clinic. Potter discovered, however, that geographic location alone could determine whether a drug bested placebo or crossed the futility boundary. By the late '90s, for example, the classic antianxiety drug diazepam (also known as Valium) was still beating placebo in France and Belgium. But when the drug was tested in the US, it was likely to fail. Conversely, Prozac performed better in America than it did in western Europe and South Africa. It was an unsettling prospect: FDA approval could hinge on where the company chose to conduct a trial.

Well, it looks like a lot of drugs on the market might not be doing anything at all. We always knew about how some people will get better just by being given a sugar pill, but thanks to big pharmaceutical massive advertising, placebos are getting more effective. Interesting that they can have different effects in different parts of the world, too.
 
Well, it looks like a lot of drugs on the market might not be doing anything at all.
The idea of article is not that drugs are doing nothing - it is that placebo became stronger, that is the riddle.

It's not that the old meds are getting weaker, drug developers say. It's as if the placebo effect is somehow getting stronger.

UPDATE: Well, after that article tells about how Big Pharma is thrown in crisis. Well, that is the way: modern phamaceutical corporations are just like legalized drug dealer, so they should be punished.
 
The idea of article is not that drugs are doing nothing - it is that placebo became stronger, that is the riddle.
Yes, well you have to wonder how much of the drug if due to the placebo effect, and how much the drug is actually doing.
 
They probably could do it on the condition taht it worked - there's nothing in the rule book about being honest, is there?
 
The placebo effect also includes biases and mistakes in the experimental procedure. Patients may be taking better care of themselves if given a drug regimen.
 
Antidepressant trials have always been a little funny.
 
I question antidepressants a bit - especially when using placebos. When going against depression, what one really needs is primarily initiative (Which is the hardest to get when depressed from what I know), but placebo effects give you a placebo initiative - or doesn't it? Aren't placebos effects that makes the body think it's improving - as depression is a chemical reaction in your brains, that is initiated by the body, will placebo medicine against depression then prevent those chemicals?

I don't know, I'm asking.
 
Relevant.

Post excerpt said:
The placebo “effect” is just that—an effect observed because of a particular situation. It does not show that there is some special benefit to sugar pills, but that when we observe people, we can measure changes that are not always due to our intended intervention. It is not possible to create strong or weak placebos, since the placebo effect is a measure of poorly defined effects and of chance alone. It is what it is.

The author of the Wired article doesn’t get it in a very profound way. I’ll give you a few laughable examples.

The fact that taking a faux drug can powerfully improve some people’s health–the so-called placebo effect–has long been considered an embarrassment to the serious practice of pharmacology.

Really? That’s not even wrong. Clinical pharmacology research depends on placebo controls to make sense of the data. The fact that certain data is affected in placebo groups does not, for example, mean everything we understand about the cytochrome P450 system is wrong.

He asserts that more and more drug studies are crapping out due to the placebo effect:

It’s not that the old meds are getting weaker, drug developers say. It’s as if the placebo effect is somehow getting stronger.

No, it’s not like that at all. Perhaps the studies are just that well done, or maybe the drugs being developed suck, or maybe companies are studying more candidate drugs and screening for efficacy. Just about any explanation that doesn’t involve aliens is better than “placebo is getting stronger”.

He goes on to talk about how placebo has become a crisis of the industry, but I have another explanation: it’s not “placebo” that’s the problem. If drugs in testing cannot outperform placebo, then the researches have done a good job of testing the drugs honestly. If the researchers are failing to develop drugs that beat placebo and the company’s bottom line is suffering, it’s not the fault of the sugar pill. Sometimes it’s either difficult or impossible to develop an effective medication. Failure is inevitable. It’s how science works. If the CEOs don’t like it, they have to either make up the data, or find a new business model.
 
Back
Top Bottom